LMARX
Price
$71.04
Change
-$0.26 (-0.36%)
Updated
Jul 31 closing price
Net Assets
705.48M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

LMARX vs NAESX

LMARX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
LMARX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMARX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. LMARX (705M). NAESX pays higher dividends than LMARX: NAESX (1.10) vs LMARX (0.00). LMARX was incepted earlier than NAESX: LMARX (20 years) vs NAESX (66 years). LMARX (1.48) is less costly to investors than NAESX (0.17). LMARX is a more actively managed with annual turnover of: 33.00 vs. NAESX (17.00). LMARX (0) and NAESX (0) have matching initial minimum investment requirements. NAESX annual gain was more profitable for investors over the last year : 22.56 vs. LMARX (17.23). NAESX return over 5 years is better than : 34.95 vs. LMARX (-0.10).
LMARXNAESXLMARX / NAESX
Total Expense Ratio1.450.17853%
Annual Report Gross Expense Ratio1.480.17871%
Fund Existence20 years66 years-
Gain YTD15.19414.563104%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets705M189B0%
Annual Yield % from dividends0.001.10-
Returns for 1 year17.2322.5676%
Returns for 3 years17.4743.3040%
Returns for 5 years-0.1034.95-0%
Returns for 10 years48.68155.2831%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv